An interventional study of Aerobic Exercises and Transcutaneous electrical nerve stimulation in Fibromyalgia Syndrome, sponsored by Ahmed Alshimy. Recruiting at 1 site in Egypt. Open to participants aged 25 Years to 35 Years. Per ClinicalTrials.gov, last updated 2024-08-06.
Sponsored by Ahmed Alshimy · Not applicable, Interventional, and Treatment
Among 31 studies in Fibromyalgia with a site in Egypt — 17 open to participants now, 17 under way, none of them phase 3. Fibromyalgia · Egypt.
Among the 31 studies in Fibromyalgia with a site in Egypt, this one is the 20th largest by planned enrollment of the 26 interventional ones that give a count, is one of 6 that started in 2024, is one of 24 with no phase, reaches primary completion later than 6 of the 16 other live ones, and was the 18th registered.
1,243 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.
This study's planned enrollment of 40 is below the median of 60 across 937 interventional studies indexed under Fibromyalgia.
Browse Fibromyalgia studies →17 of the 31 studies in Fibromyalgia with a site in Egypt are open now, in 1 country. Each count lists the studies.
Of the 160 Fibromyalgia studies recruiting now, 50 (31%) set no upper age limit and 96 (60%) stop at 75 or younger; 14 take children under 18; 35 take healthy volunteers.
This study: 25 Years to 35 Years · all sexes · no healthy volunteers.
The full table on the hub →31 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 6 started in 2024.
Median enrollment 60 across the 26 interventional studies, 70 across the 5 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
None of the 31 has an industry lead sponsor. The 10 most frequent:
Ahmed Alshimy is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Ahmed Alshimy has 1 study filed under Fibromyalgia — fewer than ten, so there is no comparison to draw.
4 of the studies in Fibromyalgia with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07531654Cairo UniversityComparative Effectiveness of Standard and Modified Laser Therapy in Myofascial Pain Management. | 2026-11-12 |
| NCT07390851Cairo UniversityMagnesium Sulfate as an Adjuvant to Lidocaine in MPDS Trigger Point Injections Assessed by VAS and sEMG. | 2026-11-26 |
| NCT07572994Cairo UniversityEvaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome | 2027-04-01 |
| NCT07753018Ain Shams UniversityEffects of Curcumin-Piperine Supplementation in Fibromyalgia | 2027-06-20 |
Among the 31 studies in Fibromyalgia with a site in Egypt, from their registry updates:
Fibromyalgia is the third most common musculoskeletal condition in terms of prevalence, after lumbar pain and osteoarthritis. Its prevalence is around 2-4 % and is more frequent in women than in men; the prevalence is highest in age the range of 40-60 years.
Group A (Control Group): Patients will receive exercises, and sham Non-Invasive Neuromodulation, 3 sessions per week (one hour for each session) for 4 weeks.
Group B (Study Group): Patients will receive exercises as in group (A) in addition to Non-Invasive Neuromodulation 3 sessions per week (one hour for each session) for 4 weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive exercises, and sham Non-Invasive Neuromodulation, 3 sessions per week (one hour for each session) for 4 weeks.
Other: Aerobic Exercises · Other: Transcutaneous electrical nerve stimulation
Patients will receive exercises as in group (A) in addition to Non-Invasive Neuromodulation 3 sessions per week (one hour for each session) for 4 weeks.
Other: Aerobic Exercises
Treadmill 20 minutes including 5 minutes warm up and 5 minutes cool.
will be applied for all patients, which uses an asymmetrical biphasic alternating current in the continuous mode (pulse duration 100 µs, low frequency). TENS intensity will increase slowly, and patients will be instructed to indicate sensory threshold (ST); then, the intensity are going to increase until the sensation perceived as "strong but comfortable" (SC1). The duration will be for 30 minutes, 3times/ week for 4 weeks
Pain Numeric Pain Rating Scale
Assessment of pain intensity (0-no pain, 10-most intense pain)
Time frame: 4 weeks
Biochemical analysis
Assessment of pain intensity through the change of blood cortisol level, plasma cytokine level, antinuclear antibody (ANA) level. Blood samples will be taken between the hours of 08:00-09:00 in the morning. Two blood samples will be taken from the patients before and after treatment.
Time frame: 4 weeks
Fibromyalgia Impact Questionnaire
Assess functional outcome
Time frame: 4 weeks
Pressure Pain Thresholds
Assess pain sensitivity through pressure algometer
Time frame: 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2024; primary completion for Apr 2025, 7 months later.
Of 436 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 7 months is below that.
Counting every sponsor, half of 449 studies reached it within 15 months; a quarter within 6 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ahmed Alshimy